Published in Am J Physiol on April 01, 1992
Acetylcholine beyond neurons: the non-neuronal cholinergic system in humans. Br J Pharmacol (2008) 3.39
Muscarinic receptor signaling in the pathophysiology of asthma and COPD. Respir Res (2006) 1.69
The effect of lung volume reduction surgery on chronic obstructive pulmonary disease exacerbations. Am J Respir Crit Care Med (2007) 1.68
Identification of Potential Novel Biomarkers and Signaling Pathways Related to Otitis Media Induced by Diesel Exhaust Particles Using Transcriptomic Analysis in an In Vivo System. PLoS One (2016) 1.38
Role of tiotropium in the treatment of COPD. Int J Chron Obstruct Pulmon Dis (2007) 0.99
Pro-inflammatory mechanisms of muscarinic receptor stimulation in airway smooth muscle. Respir Res (2010) 0.87
Cholinergic regulation of airway inflammation and remodelling. J Allergy (Cairo) (2012) 0.86
Muscarinic receptor antagonists: effects on pulmonary function. Handb Exp Pharmacol (2012) 0.83
Pharmacological characterisation of the interaction between glycopyrronium bromide and indacaterol fumarate in human isolated bronchi, small airways and bronchial epithelial cells. Respir Res (2016) 0.79
Preventing and managing exacerbations in COPD--critical appraisal of the role of tiotropium. Int J Chron Obstruct Pulmon Dis (2010) 0.78
Effects of atropine and propranolol on lung inflammation in experimental envenomation: comparison of two buthidae venoms. J Venom Anim Toxins Incl Trop Dis (2013) 0.77
Involvement of Cholinergic and Adrenergic Receptors in Pathogenesis and Inflammatory Response Induced by Alpha-Neurotoxin Bot III of Scorpion Venom. Inflammation (2016) 0.75
Laminin--a glycoprotein from basement membranes. J Biol Chem (1979) 12.49
A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med (1999) 10.62
Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution. J Appl Physiol (1985) (1986) 6.86
Increased nitric oxide in exhaled air of asthmatic patients. Lancet (1994) 5.39
Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J (2008) 5.38
Interstitial lung diseases of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract (first of two parts). N Engl J Med (1984) 3.73
Distribution and immunoelectron microscopic localization of laminin, a noncollagenous basement membrane glycoprotein. Lab Invest (1980) 3.64
Isolation of a heparan sulfate-containing proteoglycan from basement membrane. Proc Natl Acad Sci U S A (1980) 3.57
Chicken soup inhibits neutrophil chemotaxis in vitro. Chest (2000) 3.48
Enzyme-linked immunoassay (ELISA) for connective tissue components. Anal Biochem (1980) 3.28
Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma. JAMA (1994) 3.03
New enzyme immunoassays for measurement of influenza A/Victoria/3/75 virus in nasal washes. Lancet (1980) 2.35
Production of fibronectin by the human alveolar macrophage: mechanism for the recruitment of fibroblasts to sites of tissue injury in interstitial lung diseases. Proc Natl Acad Sci U S A (1981) 2.34
Human alveolar macrophage growth factor for fibroblasts. Regulation and partial characterization. J Clin Invest (1982) 2.33
Immunogenicity and smoking-cessation outcomes for a novel nicotine immunotherapeutic. Clin Pharmacol Ther (2011) 2.33
Interstitial lung diseases of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract. N Engl J Med (1984) 2.30
Human type III collagen gene expression is coordinately modulated with the type I collagen genes during fibroblast growth. Biochemistry (1986) 2.28
Acute and chronic effects of cigarette smoking on exhaled nitric oxide. Am J Respir Crit Care Med (1995) 2.28
Antielastases of the human alveolar structures. Implications for the protease-antiprotease theory of emphysema. J Clin Invest (1981) 2.20
Modulation of airway epithelial cell ciliary beat frequency by nitric oxide. Biochem Biophys Res Commun (1993) 2.14
Cigarette smoke induces interleukin-8 release from human bronchial epithelial cells. Am J Respir Crit Care Med (1997) 2.12
Antibodies to laminin in Chagas' disease. J Exp Med (1982) 2.11
Familial idiopathic pulmonary fibrosis. Evidence of lung inflammation in unaffected family members. N Engl J Med (1986) 1.90
Collection and analysis of exhaled breath condensate in humans. Am J Respir Crit Care Med (2001) 1.82
Modulation of alveolar macrophage-driven fibroblast proliferation by alternative macrophage mediators. J Clin Invest (1986) 1.82
Induction of cyclo-oxygenase-2 by cytokines in human pulmonary epithelial cells: regulation by dexamethasone. Br J Pharmacol (1994) 1.82
Quality of life in ALS depends on factors other than strength and physical function. Neurology (2000) 1.70
Neutrophil chemotactic factors in bacterial pneumonia. Chest (1989) 1.69
Lower respiratory tract lactoferrin and lysozyme arise primarily in the airways and are elevated in association with chronic bronchitis. J Lab Clin Med (1990) 1.67
Pulmonary macrophages can stimulate cell growth of bovine bronchial epithelial cells. Am J Respir Cell Mol Biol (1990) 1.66
Pathogenesis of the granulomatous lung diseases. Am Rev Respir Dis (1984) 1.64
Role of fibronectin as a growth factor for fibroblasts. J Cell Biol (1983) 1.64
Normal human alveolar macrophages obtained by bronchoalveolar lavage have a limited capacity to release interleukin-1. J Clin Invest (1984) 1.61
Intraluminal airway inflammation in chronic bronchitis. Characterization and correlation with clinical parameters. Am Rev Respir Dis (1989) 1.58
Characterization of the lower respiratory tract inflammation of nonsmoking individuals with interstitial lung disease associated with chronic inhalation of inorganic dusts. Am Rev Respir Dis (1987) 1.57
Effects of aerosolized surfactant in patients with stable chronic bronchitis: a prospective randomized controlled trial. JAMA (1997) 1.56
Prostaglandin E(2) inhibits fibroblast chemotaxis. Am J Physiol Lung Cell Mol Physiol (2001) 1.55
Augmentation of functional prostaglandin E levels on the respiratory epithelial surface by aerosol administration of prostaglandin E. Am Rev Respir Dis (1991) 1.49
Effect of a nitric oxide synthase inhibitor and a glucocorticosteroid on exhaled nitric oxide. Am J Respir Crit Care Med (1995) 1.47
Neutrophilic respiratory tract inflammation and peripheral blood neutrophilia after grain sorghum dust extract challenge. Chest (1995) 1.42
The smoking cessation efficacy of varying doses of nicotine patch delivery systems 4 to 5 years post-quit day. Prev Med (1999) 1.42
Procollagen production and procollagen messenger RNA levels and activity in human lung fibroblasts during periods of rapid and stationary growth. J Biol Chem (1981) 1.41
Effect of transdermal nicotine delivery as an adjunct to low-intervention smoking cessation therapy. A randomized, placebo-controlled, double-blind study. Arch Intern Med (1991) 1.38
Pulmonary oxygen toxicity. Early reversible changes in human alveolar structures induced by hyperoxia. N Engl J Med (1983) 1.38
Regional distribution of emphysema: correlation of high-resolution CT with pulmonary function tests in unselected smokers. Radiology (1992) 1.36
Capacity for substrate utilization in oxidative metabolism by neurons, astrocytes, and oligodendrocytes from developing brain in primary culture. J Neurosci Res (1987) 1.33
Fibronectin in human bronchopulmonary lavage fluid. Elevation in patients with interstitial lung disease. J Clin Invest (1982) 1.31
Regulation of fibroblast proliferation in three-dimensional collagen gel matrix. In Vitro Cell Dev Biol Anim (1997) 1.28
Acetaldehyde-stimulated PKC activity in airway epithelial cells treated with smoke extract from normal and smokeless cigarettes. Proc Soc Exp Biol Med (2000) 1.25
Immunological functions of the pulmonary epithelium. Eur Respir J (1995) 1.22
Are higher doses of nicotine replacement more effective for smoking cessation? Nicotine Tob Res (1999) 1.22
Smoke and viral infection cause cilia loss detectable by bronchoalveolar lavage cytology and dynein ELISA. Am J Respir Crit Care Med (1994) 1.21
Hormonal requirements for basement membrane collagen deposition by cultured rat mammary epithelium. Lab Invest (1979) 1.20
Evidence for chronic inflammation as a component of the interstitial lung disease associated with progressive systemic sclerosis. Am Rev Respir Dis (1985) 1.20
Transplanted BM and BM side population cells contribute progeny to the lung and liver in irradiated mice. Cytotherapy (2003) 1.19
Elevation of nitrotyrosine and nitrate concentrations in cystic fibrosis sputum. Pediatr Pulmonol (2000) 1.18
Effect of collagen and cell shape on binding of fibronectin to cells. Arch Biochem Biophys (1981) 1.18
Complement activation in cystic fibrosis respiratory fluids: in vivo and in vitro generation of C5a and chemotactic activity. Pediatr Res (1986) 1.17
Cigarette smoke inhibits lung fibroblast proliferation and chemotaxis. Am J Respir Crit Care Med (1995) 1.13
Patterns of pulmonary structural remodeling after experimental paraquat toxicity. The morphogenesis of intraalveolar fibrosis. Am J Pathol (1985) 1.13
Total indoor smoking ban and smoker behavior. Prev Med (1992) 1.12
Lower respiratory tract iron burden is increased in association with cigarette smoking. J Lab Clin Med (1991) 1.12
Activation of the complement system in the adult respiratory distress syndrome. Am Rev Respir Dis (1987) 1.12
Quantitative culture of bronchoalveolar lavage fluid for the diagnosis of bacterial pneumonia. Am J Med (1993) 1.12
Bronchoscopy with bronchoalveolar lavage causes neutrophil recruitment to the lower respiratory tract. Am Rev Respir Dis (1991) 1.11
Paraquat-induced pulmonary fibrosis. Role of the alveolitis in modulating the development of fibrosis. Am Rev Respir Dis (1984) 1.11
Preparation of collagen substrates for cell attachment: effect of collagen concentration and phosphate buffer. Anal Biochem (1979) 1.09
Cigarette smoke inhibits human bronchial epithelial cell repair processes. Am J Respir Cell Mol Biol (2001) 1.08
Complement activation by cigarette smoke. Am J Physiol (1991) 1.08
NIH conference. Airway inflammation. Ann Intern Med (1995) 1.08
Adhesion characteristics of murine metastatic and nonmetastatic tumor cells in vitro. Cancer Res (1980) 1.07
The role of cigarette smoke in the pathogenesis of asthma and as a trigger for acute symptoms. Curr Opin Pulm Med (1999) 1.07
TNF-alpha and IL-1 beta upregulate nitric oxide-dependent ciliary motility in bovine airway epithelium. Am J Physiol (1995) 1.06
An enzyme-linked immunoassay for the cartilage proteoglycan. Arch Biochem Biophys (1981) 1.04
Contraction of fibroblast-containing collagen gels: initial collagen concentration regulates the degree of contraction and cell survival. In Vitro Cell Dev Biol Anim (2001) 1.04
Respiratory tract inflammation in swine confinement workers studied using induced sputum and exhaled nitric oxide. J Toxicol Clin Toxicol (1998) 1.04
Aerosolized beclomethasone in chronic bronchitis. Improved pulmonary function and diminished airway inflammation. Am Rev Respir Dis (1992) 1.04
Pathogenesis, evaluation, and therapy for massive hemoptysis. Clin Chest Med (1992) 1.02
Cytokine inhibition of fibroblast-induced gel contraction is mediated by PGE(2) and NO acting through separate parallel pathways. Am J Respir Cell Mol Biol (2001) 1.02
Collaborative interactions between neutrophil elastase and metalloproteinases in extracellular matrix degradation in three-dimensional collagen gels. Respir Res (2001) 1.02
The Goodpasture-like syndrome in mice induced by intravenous injections of anti-type IV collagen and anti-laminin antibody. Am J Pathol (1982) 1.01
Airway epithelial cells: functional roles in airway disease. Am J Respir Crit Care Med (1994) 1.01
Aprotinin and methylprednisolone equally blunt cardiopulmonary bypass-induced inflammation in humans. J Thorac Cardiovasc Surg (1995) 1.01
Cigarette smoke extract inhibits fibroblast-mediated collagen gel contraction. Am J Physiol (1998) 1.01
Ketone body metabolism in the neonate: development and the effect of diet. Fed Proc (1985) 1.01
Cyclooxygenase metabolites are compartmentalized in the human lower respiratory tract. J Appl Physiol (1985) (1987) 1.00
Mechanisms of neutrophil recruitment to the lung by grain dust exposure. Am Rev Respir Dis (1988) 0.99
Respiratory tract responses to dust: relationships between dust burden, lung injury, alveolar macrophage fibronectin release, and the development of pulmonary fibrosis. Toxicol Appl Pharmacol (1990) 0.99
Synergistic neutrophil elastase-cytokine interaction degrades collagen in three-dimensional culture. Am J Physiol Lung Cell Mol Physiol (2001) 0.98
The effect of alcohol ingestion on exhaled nitric oxide. Eur Respir J (1996) 0.97
Exhaled nitric oxide is increased in asthma. Chest (1995) 0.96